NAFDAC
NAFDAC is Nigeria's federal statutory regulator of food, drugs, chemicals, cosmetics, medical devices, vaccines, veterinary products and narcotics, licensing and testing regulated products through digital portals and laboratories, and enforcing compliance via a nationwide field network of offices, ports and laboratories.
- Company typePrivate
- Founded2004
- HeadquartersAbuja, Nigeria
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What NAFDAC does
The National Agency for Food and Drug Administration and Control (NAFDAC) is the federal statutory regulator of Nigeria, established under Act Cap N1, Laws of the Federation of Nigeria 2004 and headquartered at Plot 2032, Olusegun Obasanjo Way, Zone 7, Wuse, Abuja, with a major operation office in Isolo, Lagos. It regulates and controls the manufacture, importation, exportation, advertisement, distribution, sale and use of food, drugs, cosmetics, medical devices, vaccines and biologicals, veterinary and allied products, pesticides and agrochemicals, and narcotics and controlled substances. Its mandate is both a gatekeeper - no regulated product may be manufactured, imported or sold without NAFDAC authorisation - and an enforcement body, operating through state offices, six zonal investigation and enforcement offices, laboratory directorates and ports inspection points. It serves pharmaceutical manufacturers and importers, food and beverage processors, cosmetic and chemical marketers, agrochemical suppliers and dealers, veterinary product makers, clinical trial sponsors, and, through public reporting channels, healthcare professionals and consumers.
The agency's technical estate is a multi-module regulatory technology stack. The NAFDAC Traceability Information System captures custody-change events from manufacturer to point of care in real time, and the Scan2Verify application lets health workers read GS1-compliant 2D DataMatrix codes and check authenticity against the NAFDAC Green Book; over 965 Android-enabled scanners are deployed nationwide and a COVID-19 pilot serialised more than one million product packs across 358 locations. The NAFDAC Automated Product Administration and Monitoring System (NAPAMS) underpins pesticide active-ingredient review, the NAFDAC Electronic Clinical Trial Application Platform (NAFDAC-eCTAP) handles trial applications, amendments, progress reports and investigational product import, the Improved Med Safety App accepts reports of substandard or falsified products and adverse drug reactions on Android, iOS, web and desktop, and the Integrated Regulatory Information Management System (IRIMS) is the intended backbone for progression from WHO Maturity Level 3 toward Maturity Level 4 and WHO-Listed Authority status. Laboratory analytical capability is a material part of the stack: the Central Drug Control Laboratory attained WHO Prequalification in September 2023 and five of seven NAFDAC laboratories are ISO 17025 certified.
The business model is statutory rather than commercial. Revenue mechanics comprise non-recurring registration, listing and permit fees set by the published NAFDAC Tariff and differentiated by enterprise size and product category, fee-based laboratory analysis and lot release of vaccines and biologicals, and statutory government funding from the federal budget complemented by internally generated revenue. Published per-application fees include N36,737.50 for micro-scale food registration and N41,000.00 for micro-scale cosmetics, with no subscription or SaaS pricing; published processing timelines run to 90 working days for food registration and 240 working days for drug registration. Demand is broad and effectively mandatory rather than discretionary, since every regulated product, renewal and variation generates a fee event, and demand is distributed across a very long tail of MSMEs and cottage industries alongside a small number of large industrial manufacturers and importers. Digital delivery is the primary channel: e-Registration, dossier submission, e-Clearance, e-License/LPCO via the National Single Window, the Green Book, eCTAP, and complaint hotlines and email reporting.
NAFDAC firmographics
Firmographics- Name
- NAFDAC
- Legal name
- National Agency for Food and Drug Administration and Control (NAFDAC)
- Website
- https://nafdac.gov.ng
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- NAFDAC is Nigeria's federal statutory regulator of food, drugs, chemicals, cosmetics, medical devices, vaccines, veterinary products and narcotics, licensing and testing regulated products through digital portals and laboratories, and enforcing compliance via a nationwide field network of offices, ports and laboratories.
- Ownership category
- akta.pro rank
NAFDAC industry classification
Industry- Product category
- Government Health and Food Safety Regulation
- NAICS
- Other Scientific and Technical Consulting Services (541690), Testing Laboratories and Services (541380), Testing Laboratories and Services (54138)
- SIC
- Services-Testing Laboratories (8734), Services-Medical Laboratories (8071)
- akta.pro industry
- Drug Regulators (Human Pharmaceuticals)Healthcare & Life Sciences/Public Health, Government & Regulators/Medicines & Healthcare Product Regulators (Drugs/Biologics/Devices)Regulatory Submissions, Registrations & Facility Approvals (FDA/USDA/EU)Agriculture & Food Production/Food Safety, Testing & Certification/Regulatory Compliance Testing & Consulting (FDA/USDA/EFSA, HACCP)Regulatory Consulting & Compliance Program Management (FDA/USDA/EFSA)Agriculture & Food Production/Food Safety, Testing & Certification/Regulatory Compliance Testing & Consulting (FDA/USDA/EFSA, HACCP)Import/Export & Border Compliance Support (FSVP, Prior Notice, Health Certificates)Agriculture & Food Production/Food Safety, Testing & Certification/Regulatory Compliance Testing & Consulting (FDA/USDA/EFSA, HACCP)Inspection Readiness & Regulatory Authority Support (FDA/EMA/MHRA)Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
Keywords
Where NAFDAC is headquartered
LocationHeadquarters
- HQ city
- Abuja
- HQ country
- Nigeria
- HQ region
- Africa
Offices9 records
Markets served
NAFDAC business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D
Revenue model
- Product registration, licensing and permit fees (tariffs): Non-recurring statutory fees charged to applicants for product registration, listing certificates and NAFDAC registration numbers, differentiated by enterprise size (micro-scale, small-scale) and product category (food, cosmetics, drugs). Registration is mandatory for all regulated products, so demand is broad and recurring in the sense that each product, renewal and variation generates a fee event.
- Laboratory analysis and testing services: Fee-based laboratory analysis of product samples, raw materials and finished products (including lot release of human vaccines and biologicals) provided through NAFDAC's central and zonal laboratories, and applied during registration, surveillance and enforcement.
- Statutory government funding for regulatory operations: NAFDAC is a federal government agency established under Act Cap N1, LFN 2004, and its core regulatory functions are funded by the federation, complemented by internally generated revenue; some published research is partly funded by Internally Generated Revenue, Global Fund, BMGF, WHO and USAID.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | One time/ perpetual license | Micro-scale food business registration fee |
| Unit Pricing | One time/ perpetual license | Micro-scale cosmetic business registration fee |
| Other | One time/ perpetual license | Full industrial-scale registration tariffs |
Go-to-market motion5 records
Distribution channels6 records
Marketing channels8 records
NAFDAC product offering
Product offeringCore offering
NAFDAC is Nigeria's federal statutory agency for regulating and controlling the manufacture, importation, exportation, advertisement, distribution, sale and use of food, drugs, chemicals, cosmetics, medical devices, bottled water, detergents, pesticides and agrochemicals, veterinary products, vaccines, biologicals and narcotics, established under Act Cap N1, Laws of the Federation of Nigeria 2004. It sells regulatory authorisation and compliance services to regulated industry: product registration and marketing authorisation (including listing certificates and NAFDAC registration numbers), clinical trial authorisation, GMP and GSDP inspection and classification, laboratory testing and lot release of vaccines and biologicals, market surveillance, product recalls, blacklisting and watchlisting, and public safety alerts. These services are delivered through statutory fees and tariffs, supported by a portfolio of digital platforms (e-Registration, e-Clearance, e-License, Dossier Submission Portal, NAFDAC-eCTAP, Green Book, Med Safety App, Traceability Information System with Scan2Verify) and a physical enforcement network of state and zonal offices, laboratories and ports inspection directorates.
Product overview
NAFDAC (National Agency for Food and Drug Administration and Control) is a single federal regulatory agency rather than a commercial platform vendor, but it operates a distinctly multi-module digital and regulatory service portfolio covering food, drugs, chemicals, veterinary products, vaccines/biologicals/medical devices, cosmetics and narcotics. The core digital layer consists of the NAFDAC e-Services set — e-Registration, the Dossier submission portal, NAFDAC e-Clearance (ports), NAFDAC e-License/Permits (LPCO), the NAFDAC Green Book and Registered Products Database, the Clinical Trial Database and the NAFDAC-eCTAP clinical trial application platform — backed internally by the NAFDAC Automated Product Administration and Monitoring System (NAPAMS) and the Integrated Regulatory Information Management System (IRIMS). Layered on top are enforcement and surveillance modules: the Med Safety App (public reporting of substandard/falsified products and adverse drug reactions), the Pharmaceutical Traceability Information System (TIS) with the Scan2Verify app and GS1 DataMatrix verification, the Blacklist and Watchlist of Companies registers, the Market Authorization Withdrawal register and the Recall/Safety Alert and Field Safety Notice systems. These modules are complemented by policy programmes such as the 5+5 Policy for local pharmaceutical manufacturing, the MNCH+N and COVID-19 traceability pilots, and the WHO Global Benchmarking Tool Maturity Level 3 (ML3) regulatory framework toward ML4.
Differentiator
Problem solved
Functional benefit
Brands
- Med Safety App: NAFDAC's digital platform (Android, iOS, web and desktop) for reporting suspected substandard and falsified medical products and adverse drug reactions directly to the Agency.
- Scan2Verify
Products and services
- Med Safety App Public and healthcare-provider reporting application for suspected substandard and falsified medical products and adverse drug reactions, allowing users to submit reports, upload photographs of suspicious products and provide details that support rapid investigation and regulatory action. Available on Android and iOS, plus web and desktop versions.
- NAFDAC-eCTAP (Electronic Clinical Trial Application Platform) Online platform for submitting clinical trial applications, amendments and progress/final reports, and for facilitating importation of investigational medicinal products, built in partnership with NUVOTEQ with Gates Foundation support. Intended for clinical trial sponsors, principal investigators and research institutions.
- NAFDAC Traceability Information System (TIS) The operational backbone of Nigeria's national pharmaceutical traceability programme, capturing custody-change events across the supply chain from manufacturer to point of care in real time under the NAFDAC Pharmaceutical Products Traceability Regulation published in October 2024. Used by manufacturers, distributors and health workers to trace regulated packs.
- Scan2Verify Mobile application that lets health workers scan GS1-compliant 2D DataMatrix codes to verify product authenticity against the NAFDAC Green Book and capture custody-change events; over 965 Android-enabled mobile scanners are deployed across states and healthcare facilities nationwide.
- NAFDAC Green Book (Registered Drug Database) Public database of NAFDAC-registered products, used as the authenticity reference point for the Scan2Verify traceability app and as the source for the NAFDAC e-License offering. Publicly searchable by consumers, supply chain actors and health workers to verify registration status.
- NAFDAC e-Registration Online portal where applicants submit registration documents and applications for NAFDAC-regulated products, including MSME product registration with upload of required documentation. Provides application forms, templates, pre-shipment inspection and testing agent lists, and e-Certificate enrolment.
- NAFDAC Dossier Submission Portal Portal for submitting product dossiers for regulatory review, supported by a published Dossier Submission Guide and a web-based Dossier Management System (DMS). Used by manufacturers and importers submitting dossiers for marketing authorisation.
- NAFDAC e-Clearance Electronic clearance portal used for port/import clearance processes of regulated products at Nigerian ports of entry, operated by the Port Inspection Directorate for importers.
- NAFDAC e-License/Permits (LPCO) Electronic licensing and permit service for NAFDAC-regulated products, accessed through the National Single Window (nsw.gov.ng) portal for manufacturers and importers requiring Licences, Permits and Certificates of No Objection.
- Pharmacovigilance & Post-Market Surveillance Post-marketing surveillance service covering pharmacovigilance reporting, adverse drug reaction and adverse event reporting for medical devices and IVDs, and expanded surveillance from marketplaces to healthcare facilities nationwide, with adverse drug reaction reports submitted via the WHO UMC VigiFlow eForms endpoint.
- Inspection Classification Database Public database of GSDP inspection classifications, foreign finished pharmaceutical products with valid licences, lists of finished pharmaceutical product manufacturers, cold chain inspections and clinical trial/GCP inspection records, used by industry and investors to check the compliance status of facilities.
- NAFDAC Automated Product Administration and Monitoring System (NAPAMS) Database of registered pesticide active ingredients and other product registrations, used for the 2022 regulatory review of pesticides in Nigeria alongside scientific evidence and expert input to drive restrictions, reclassification, phase-out or prohibition decisions.
- Integrated Regulatory Information Management System (IRIMS) Digital regulatory information management system underpinning NAFDAC's ongoing digital transformation on its path from WHO Maturity Level 3 to Maturity Level 4 and WHO-Listed Authority status, with expanded oversight of emerging health technologies planned.
- 5+5 Policy Regulatory directive instituting local manufacturing of selected drug products to phase out imports and strengthen national drug security, implemented through facility layout reviews, contract manufacturing partnerships, cGMP retrofit and inspection support for manufacturers. As of March 2026, 185 of 191 facility layout applications had been approved (97%), with 20 completed and 88 under construction.
- Registered Products Database Public database of registered NAFDAC-regulated products, providing transparency on authorised products and their registration status for consumers, regulators and supply chain actors.
- Blacklist of Companies Regularly updated public record of companies found to violate regulatory standards; blacklisted companies are prohibited from engaging in regulated product activities until corrective action and regulatory clearance are granted.
- Watchlist of Companies Public post-market surveillance register of companies demonstrating serious or repeated non-compliance, with case reference numbers, product names, market authorization holders, registration status and risk levels (critical/high/medium).
- Market Authorization Withdrawal Register Register of products officially withdrawn, suspended or cancelled by NAFDAC for commercial or safety reasons or through deregistration, no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale or use in Nigeria.
- Clinical Trial Database Database of clinical trial applicants and authorised trials in Nigeria, listing study title, phase, sponsor, principal investigator, trial sites, authorisation status and GCP inspection outcomes.
Quantifiable outcome
- Importation of 5+5 and Ceiling 36 medicines reduced from 70% to about 50%, with over 70% of affected products now made locally
- +7 more outcomes
Companies that use NAFDAC
Customer profileNamed customers8 records
Segments8 records
Ideal customer profiles6 records
NAFDAC technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature7 records
NAFDAC partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core, flagship and supporting.
- African national regulatory authoritiescoreNAFDAC and African regulators are seeking a stronger continental food safety system, including participation in continental meetings to advance traceability adoption across African countries. NAFDAC also hosts the African ML3 National Regulatory Agencies Meeting in Abuja (July 2025).
- Nigerian PolicecoreNAFDAC and the Police partnered on enforcement of the ban on sachet alcohol, with street-by-street alcohol crackdowns and nationwide enforcement of the sachet and small PET bottle ban. The collaboration supports seizures, arrests and prosecution of traders in banned alcohol.
- World Health Organization (WHO)flagshipWHO conducts the Global Benchmarking Tool assessment and recertification of NAFDAC as a National Regulatory Authority, recertifying the Agency at Maturity Level 3 on June 30, 2025. WHO also provided WHO Prequalification for the Central Drug Control Laboratory in September 2023 and supports NAFDAC's reforms and regulatory science strengthening.
- Pharmaceutical Council of Nigeria (PCN)coreNAFDAC and the Pharmaceutical Council of Nigeria held a joint press briefing on the Coordinated Wholesale Centre in Kano (November 2024), and PCN co-announced the ML3 retention in August 2025. The partnership covers coordinated wholesale centres and the evacuation of open drug markets, with coordinated wholesale centres also established for the Kano open drug markets of Sabon Gari, Malam Kato and Mai Karaimi (February 2024).
- Danish Embassy and Danish Veterinary and Food AgencysupportingThe Danish Embassy and the Danish Veterinary and Food Agency partnered with NAFDAC to combat antimicrobial resistance. The partnership supports NAFDAC's anti-microbial resistance (AMR) programme within the Veterinary and Allied Products directorate and the one-health triad approach.
- GS1 NigeriaflagshipA Memorandum of Understanding with GS1 Nigeria formalised a partnership for training, capacity building and deployment support for Nigeria's pharmaceutical traceability programme. The collaboration underpins use of globally recognised GS1 Standards in the Nigeria National Pharmaceutical Traceability Strategy and the NAFDAC Traceability Information System with GS1-compliant 2D DataMatrix codes and the Scan2Verify mobile application.
- NUVOTEQcoreNAFDAC launched the NAFDAC Electronic Clinical Trial Application Platform (NAFDAC-eCTAP) in partnership with NUVOTEQ. The platform provides a seamless, transparent system for submitting clinical trial applications, amendments and progress/final reports and facilitates importation of investigational medicinal products. It is described as the first electronic application platform of its kind in Africa.
- National Human Research Ethics Council (NHREC)coreNAFDAC and NHREC jointly announce mandatory stakeholder training on clinical trial regulations in Nigeria, coordinating implementation of clinical trial application and GCP requirements. The arrangement links NAFDAC's NAFDAC-eCTAP platform with ethics review for trial sponsors and investigators.
- Standards Organisation of Nigeria (SON) and Federal Competition and Consumer Protection Commission (FCCPC)coreNAFDAC works with sister agencies SON and FCCPC on large scale food fortification in compliance with Nigerian Industrial Standards, and on related food quality initiatives such as the market-level large-scale food fortification (LSFF) digital monitoring and compliance survey. The agencies are also linked on NAFDAC's website as regulatory partners.
- Crop LifesupportingNAFDAC works with stakeholders such as Crop Life for grass-root implementation of the phased banning of pesticides that could make food unsafe (running from 2021 to date). The collaboration supports farmer and agro-input dealer training and market surveillance against banned agrochemicals.
- Nigeria Customs ServicesupportingCustoms reported to NAFDAC that fake NAFDAC registration documents were being used to smuggle drugs into Nigeria, prompting joint regulatory and border-control scrutiny of imported products. NAFDAC's port and border control checks are conducted in collaboration with relevant border and law-enforcement agencies.
- Federal Ministry of Health and Social Welfare and nutrition partnerssupportingNAFDAC joined the Federal Ministry of Health and Social Welfare, nutrition partners and the global community in celebrating World Breastfeeding Week in 2025 and 2026, with capacity-building events for healthcare professionals, supporting infant and young child nutrition objectives.
Scale indicators26 records
Recent moves6 records
Expansion highlights7 records
NAFDAC competitors and assessment
Company assessmentRegional players
- South African Health Products Regulatory Authority (SAHPRA): South Africa's national medicines, medical device and cosmetics regulator, admitted to the ICH alongside NAFDAC at the 51st ICH Assembly in November 2025. It operates the same regulatory stack (registration, GMP inspection, laboratory testing, pharmacovigilance, market surveillance) for an African market, making it the closest institutional analogue to NAFDAC.
- Medicines and Healthcare products Regulatory Agency (MHRA): UK medicines and healthcare products regulator performing the same core functions as NAFDAC's Drug Evaluation and Research directorate: marketing authorisation, GMP inspection, batch testing and pharmacovigilance, with a comparable post-Brexit regulatory information management system.
- ANVISA (Agência Nacional de Vigilância Sanitária): Brazil's national health regulatory authority running food, drug, device and pesticide registration plus GMP inspection and post-market surveillance across a large emerging market, with a comparable mandate for enforcement and laboratory testing.
- Food Safety and Standards Authority of India (FSSAI): India's food safety regulator with an overlapping remit to NAFDAC's food directorate: registration of food businesses, licensing of food product categories, inspection of manufacturing units, and enforcement against adulteration and unapproved pesticides, using a similar fee-and-licence model.
- COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios): Mexico's health regulatory authority responsible for health product registration, GMP inspection, clinical trial authorisation and post-market alerts, comparable in mandate breadth and in operating an online application and alert system for regulated industry.
- Therapeutic Goods Administration (TGA): Australia's national regulator of therapeutic goods, running an e-registration/e-licensing portal, GMP inspections, a public adverse event reporting system and an Australian Register of Therapeutic Goods — the same digital-plus-enforcement service model NAFDAC operates.
Broad incumbents
- U.S. Food and Drug Administration (FDA): The largest and broadest national regulator, covering food, drugs, devices, cosmetics and tobacco with its own laboratories and surveillance network. It is the benchmark against which NAFDAC's WHO Global Benchmarking Tool maturity trajectory and traceability programmes are measured.
- European Medicines Agency (EMA): EU-level medicines regulator operating centralised scientific assessment, GMP inspection coordination and EU-wide pharmacovigilance (EudraVigilance). Relevant as the multi-country regulatory network model that NAFDAC engages with for ECOWAS harmonisation of approvals.
Others
- TraceLink: Provider of end-to-end pharmaceutical supply chain traceability and serialization networks that partner with regulators. It is the commercial analogue to the in-house NAFDAC Traceability Information System and Scan2Verify stack, and a potential partner or technology reference for extending traceability beyond pharmaceuticals.
- SGS: Global testing, inspection and certification company that sells the same fee-based testing, laboratory analysis and conformity-assessment services NAFDAC delivers commercially to applicants, but without statutory enforcement power; useful as a commercial benchmark for the agency's testing business model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
NAFDAC social profiles
Digital presenceNAFDAC compliance and trust
Trust signalCompliance9 records
NAFDAC financial estimates
Financial estimateRevenue estimate
Valuation estimate
NAFDAC leadership team
Management profileNumber of profiles
Profiles1 record
NAFDAC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NAFDAC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NAFDAC
What does NAFDAC do?
NAFDAC is Nigeria's federal statutory agency for regulating and controlling the manufacture, importation, exportation, advertisement, distribution, sale and use of food, drugs, chemicals, cosmetics, medical devices, bottled water, detergents, pesticides and agrochemicals, veterinary products, vaccines, biologicals and narcotics, established under Act Cap N1, Laws of the Federation of Nigeria 2004. It sells regulatory authorisation and compliance services to regulated industry: product registration and marketing authorisation (including listing certificates and NAFDAC registration numbers), clinical trial authorisation, GMP and GSDP inspection and classification, laboratory testing and lot release of vaccines and biologicals, market surveillance, product recalls, blacklisting and watchlisting, and public safety alerts. These services are delivered through statutory fees and tariffs, supported by a portfolio of digital platforms (e-Registration, e-Clearance, e-License, Dossier Submission Portal, NAFDAC-eCTAP, Green Book, Med Safety App, Traceability Information System with Scan2Verify) and a physical enforcement network of state and zonal offices, laboratories and ports inspection directorates.
Is NAFDAC a public or private company?
NAFDAC is a private company. It is classified as state government owned and is currently operating.
When was NAFDAC founded?
NAFDAC was founded in 2004. It employs 501 to 1,000 people.
Where is NAFDAC based?
NAFDAC is headquartered in Abuja, Nigeria, in the Africa region.
How does NAFDAC make money?
Three revenue lines are on record. Product registration, licensing and permit fees (tariffs) is the primary driver. The others are laboratory analysis and testing services and statutory government funding for regulatory operations.
Who are NAFDAC's main competitors?
Regional players on record are South African Health Products Regulatory Authority (SAHPRA), Medicines and Healthcare products Regulatory Agency (MHRA), ANVISA (Agência Nacional de Vigilância Sanitária), Food Safety and Standards Authority of India (FSSAI), COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) and Therapeutic Goods Administration (TGA). Broad incumbents are U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA). Others are TraceLink and SGS.
Does NAFDAC have an API?
No public API is recorded for NAFDAC.
What industry is NAFDAC in?
NAFDAC's product category is Government Health and Food Safety Regulation. Its primary akta.pro industry code is HLAJADAA, Drug Regulators (Human Pharmaceuticals), with a secondary code of AFALADAD, Regulatory Submissions, Registrations & Facility Approvals (FDA/USDA/EU). Its NAICS code is 541690 and its SIC code is 8734.